Policies implemented in the EU on free trade of services and goods among member states. The main agenda is to have a harmonized standard, with economic benefits through a more significant and broader market.
However, this is not the case in medical products that are beneficial in health but also associated with risks. Regulations of medicinal drugs are subjected to approvals that direct in what form, where, how and when the product is sold in any of the EU nations.
A strategic corporate and commercial regulation is strictly adhered to for any sales and consumption of medicinal products in the EU. Governed by the EU Directive 2001/83/EC also known as the Consolidated Directive, the many years of drug regulations are brought into one. The directive’s primary intent is to prohibit any medicinal products sales without knowledgeable authorization.
To acquire marketing authorization, other members of the European Economic Area (EEA) have adopted the EU regulations. The regulations adhere to rules set on imports, manufacture, promotions, and branding.
There is a new development being initiated by the European Commission and Heads of Medicines Agencies to agree on how to pave the way for EPI (Electronic Product Information) in the EU. The implementation will include documents of all single medicines in the EU with a summary of product characteristics for healthcare professional and a package leaflet for patients.
By using EPI, EMA will have addressed the shortcomings of the European Commission report on means of improving medicines in the EU, and also make it easier for patients to understand the packaged drugs. Stakeholders will be involved in sharing best practices in EPI realization and assist in updating EU guidance on the preparation of the package documents.Europe-Sustainable mobility and EU Transport policies
Things are changing, and the growth of powerful transportation technologies is one of our evolutionary developments. Viewed as a significant asset in economic growth and job creator, it’s also the foundation of EU integration. The European Commission (EC) develops policies on transport and managing the funding of the Transport Networks which is worth over a billion Euros.
EU transport policies allow for a smooth connection between member states to avoid obstacles that may hinder economic growth and unfair competition in the transport sector. The fundamental forms of transport are rail, air, water, and road.
The EC mandates that the various agencies in these important transport forms provide mobility that is sustainable, environmentally friendly and energy efficient all over Europe. Transportation offers excellent growth opportunities, but it’s also dogged by significant challenges that slow the full exploitation of this opportunities.
Businesses and households are substantially affected if there are poor logistics and inefficiency in transport. This is due to the fact that transport takes a significant share of households and commercial expenditure in provision of transport services.
To add value to services and products that are produced in the EU, full optimization multimodal transport and improvement of infrastructure helps reduce logistic costs. The EU needs to address issues that reduce logistic costs to seize growth opportunities.
Adverse social conditions of transport workers are a factor that needs to be addressed mainly in rail transport. Rail has the potential for it has advantages in scale for freight and passengers over substantial distances. This combination makes it socially inclusive and environmentally friendly in reducing carbon emissions. In other developments, the EC is launching initiatives in ways to improve the workers’ conditions in road transport. There is a proposal to clarify the application of EU rules on the posting of workers to this transport sector.
http://umvp.eu/wp-content/uploads/2019/03/Pharmacy.jpg640960adminhttp://umvp.eu/wp-content/uploads/2019/03/logo_umvp2_medium.pngadmin2019-03-04 14:32:452019-03-07 13:41:55Pharmaceutical Products Information in the EU